By futureTEKnow | Editorial Team
In a move that could reshape the future of medical decision-making, OpenEvidence has secured a staggering $210 million in Series B funding, sending shockwaves through both the health tech sector and investment circles. Now valued at $3.5 billion, the Cambridge-based company’s mission is clear: bring real-time, evidence-based insights to the fingertips of clinicians using artificial intelligence built for the unique demands of modern healthcare.
The adoption curve for OpenEvidence has been nothing less than remarkable. Already active in over 10,000 hospitals and reaching 40% of US physicians, the platform is embedded into the daily rhythm of healthcare. Its secret sauce? Combining AI-powered search with partnerships spanning the American Medical Association, JAMA, and The New England Journal of Medicine—bringing trustworthy, peer-reviewed research right to the bedside.
These integrations allow OpenEvidence to sidestep the traditional scavenger hunt through fragmented databases. Instead, clinicians ask complex patient-specific questions and, within seconds, receive tailored, referenced responses—speeding up care, reducing cognitive overload, and sharply cutting research time from hours to moments.
The latest announcement turns up the dial: OpenEvidence DeepConsult™, a team of autonomous, PhD-level, medically-specialized AI agents designed for the research needs of busy physicians. Imagine asking a time-consuming question before seeing your next patient, then returning from a break to find a comprehensive research synthesis ready in your inbox. DeepConsult efficiently cross-references hundreds of studies, surfacing critical insights and even uncovering interdisciplinary connections that might otherwise go unnoticed.
For US doctors, DeepConsult™ is free, making advanced medical research as accessible as a tap on the screen—an answer to the overwhelming expansion of medical knowledge and the burnout plaguing healthcare professionals.
These innovations arrive as the industry faces a critical physician shortage and a relentless increase in the volume of medical research. OpenEvidence’s AI—trusted, fast, and always up-to-date—acts as a copilot for clinicians, empowering them to deliver the best care possible despite the pressures of understaffed hospitals and rapidly evolving medical science.
“Physicians are superheroes, and OpenEvidence is giving these superheroes new superpowers,” notes founder Daniel Nadler, underscoring the company’s commitment to making complex data actionable and keeping care at the cutting edge.
$210M Series B Funding at a $3.5B valuation.
10,000+ hospitals and 40% of US physicians use OpenEvidence daily.
AI integrates with top-tier medical journals for evidence-based responses.
DeepConsult™: AI-powered, PhD-level agents conduct in-depth research autonomously.
Offered free to US clinicians, addressing burnout and the information overload crisis.
futureTEKnow is a leading source for Technology, Startups, and Business News, spotlighting the most innovative companies and breakthrough trends in emerging tech sectors like Artificial Intelligence (AI), immersive technologies (XR), robotics, and the space industry. Since 2018, futureTEKnow has evolved from a social media platform into a comprehensive global database and news hub, delivering insightful content that connects entrepreneurs, investors, and industry professionals with the latest advancements shaping the future of business and technology.
Discover how Bedrock Robotics is transforming U.S. construction by upgrading heavy equipment with autonomous technology to address labor shortages, enhance safety, and boost efficiency.
Broadcom’s Tomahawk Ultra switch is redefining AI data center networking with ultra-low latency and robust scale-up Ethernet solutions, directly challenging NVLink and Nvidia’s grip on AI infrastructure. Explore why this switch is poised to power next-generation HPC and artificial intelligence workloads.
Learn how Amazon Bedrock AgentCore simplifies deploying and operating AI agents at scale, offering secure runtimes, memory, and identity tools for enterprises.
ByteDance, parent of TikTok, is developing ultra-lightweight mixed reality goggles with Pico. With a pocket processor and custom low-latency chips, these goggles rival Meta and Apple’s XR devices, prioritizing user comfort and immersive AR experiences.
Discover where Miso Robotics stands on its IPO journey, see current investment options, and explore what’s next for the food automation innovator.
Discover how AI is redefining the future of the workforce. From automation to entirely new careers, explore what skills and strategies workers need to stay ahead in an AI-driven economy.
Callidus Legal AI secures $10M in funding to build an advanced litigation platform from San Francisco, promising faster legal research for attorneys and law firms.
Cerebrium has raised $8.5M to scale its high-performance serverless AI infrastructure, making global, real-time AI deployment faster and easier for enterprises and innovators.
Meta is set to launch its massive 5-gigawatt AI data center—Hyperion—by 2026 in Louisiana and Ohio, redefining AI infrastructure and digital innovation with one of the world’s largest superclusters.
Discover how Amazon’s increased investment in Anthropic is accelerating AI breakthroughs, boosting cloud business, and influencing the tech scene in Miami and the US.
Canada is powering its AI future with a $98.6M investment in 23 leading projects, advancing technology, innovation, and competitive industries nationwide in 2025.
The Ax-4 crew made history with 18 days on the ISS, marking firsts for India, Poland, and Hungary, and safely returned to Earth in SpaceX’s Dragon Grace capsule.
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2025 All Rights Reserved.
